搜尋





搜尋





市場行情
/
股票
/
pvla
/

Palvella Therapeutics Inc

PVLA

添加自選

139.040USD

-11.150-7.42%

收盤 07-31 16:00（美東）報價延遲15分鐘

1.99B總市值

虧損本益比TTM

Palvella Therapeutics Inc

139.040

-11.150-7.42%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

PVLA 利潤表

您可以在這裡找到Palvella Therapeutics Inc的年度或季度收入報告，以深入了解Palvella Therapeutics Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

FY2016Q4

FY2016Q3

FY2016Q2

FY2016Q1

FY2015Q4

FY2015Q3

FY2015Q2

FY2015Q1

FY2014Q3

FY2014Q2

FY2014Q1

營業總收入

----

-100.00%0.00

-97.26%53.00K

-77.78%1.30M

263.50%19.52M

442.32%20.05M

-82.38%1.94M

-30.76%5.85M

32.36%5.37M

12.57%3.70M

-29.71%10.99M

349.81%8.44M

38.04%4.06M

-70.79%3.29M

17.89%15.63M

-89.13%1.88M

-80.58%2.94M

110.92%11.25M

55.19%13.26M

251.44%17.27M

81.33%15.13M

-54.39%5.33M

105.80%8.54M

-72.93%4.91M

112.49%8.35M

530.97%11.69M

209.09%4.15M

565.83%18.15M

400.28%3.93M

72.70%1.85M

7.75%1.34M

27.42%2.73M

89.34%785.01K

569.52%1.07M

472.85%1.25M

--2.14M

2114.32%414.61K

-77.05%160.24K

-84.15%217.62K

--18.72K

--698.23K

--1.37M

營業收入

----

-100.00%0.00

-97.26%53.00K

-77.78%1.30M

263.50%19.52M

442.32%20.05M

-82.38%1.94M

-30.76%5.85M

32.36%5.37M

12.57%3.70M

-29.71%10.99M

349.81%8.44M

38.04%4.06M

-70.79%3.29M

17.89%15.63M

-89.13%1.88M

-80.58%2.94M

110.92%11.25M

55.19%13.26M

251.44%17.27M

81.33%15.13M

-54.39%5.33M

105.80%8.54M

-72.93%4.91M

112.49%8.35M

530.97%11.69M

209.09%4.15M

565.83%18.15M

400.28%3.93M

72.70%1.85M

7.75%1.34M

27.42%2.73M

89.34%785.01K

569.52%1.07M

472.85%1.25M

--2.14M

2114.32%414.61K

-77.05%160.24K

-84.15%217.62K

--18.72K

--698.23K

--1.37M

營業費用

88.73%14.86M

663.78%11.30M

224.63%10.18M

121.45%9.25M

347.47%7.87M

-75.57%1.48M

-67.46%3.13M

-74.54%4.18M

-88.59%1.76M

-65.11%6.06M

-45.07%9.63M

2.37%16.41M

-16.41%15.42M

-10.68%17.36M

-23.98%17.54M

-20.04%16.03M

-10.86%18.45M

36.07%19.44M

44.74%23.07M

26.07%20.05M

20.89%20.69M

-23.18%14.29M

-11.68%15.94M

-9.46%15.90M

-10.98%17.12M

5.91%18.60M

11.75%18.05M

26.04%17.56M

56.48%19.23M

50.56%17.56M

77.24%16.15M

43.00%13.93M

31.44%12.29M

27.74%11.66M

30.86%9.11M

41.87%9.74M

66.13%9.35M

94.08%9.13M

62.14%6.96M

85.90%6.87M

43.59%5.63M

--4.70M

130.91%4.29M

6.53%3.69M

91.72%3.92M

--1.86M

--3.47M

--2.04M

研發費用

129.11%9.33M

7.44%7.12M

1563.68%6.53M

581.49%5.12M

314.02%4.07M

48.81%6.63M

-104.65%-446.00K

-94.76%751.00K

-92.67%984.00K

-66.71%4.45M

-29.39%9.60M

19.93%14.33M

-4.56%13.42M

-12.87%13.38M

-28.24%13.59M

-24.39%11.95M

-15.07%14.07M

44.63%15.36M

60.18%18.94M

39.42%15.80M

29.82%16.56M

-24.78%10.62M

-10.51%11.82M

-15.25%11.33M

-10.76%12.76M

8.60%14.12M

15.88%13.21M

46.07%13.37M

80.14%14.30M

146.64%13.00M

82.15%11.40M

69.67%9.15M

48.06%7.94M

-23.81%5.27M

35.42%6.26M

19.90%5.40M

46.47%5.36M

135.06%6.92M

125.28%4.62M

160.79%4.50M

140.02%3.66M

--2.94M

121.42%2.05M

54.22%1.73M

24.69%1.52M

--926.60K

--1.12M

--1.22M

折舊攤銷及損耗

----

-3.65%739.00K

30.02%758.00K

-28.40%605.00K

-5.58%575.00K

26.15%767.00K

-5.51%583.00K

35.20%845.00K

-11.48%609.00K

-19.36%608.00K

16.42%617.00K

84.37%625.00K

159.62%688.00K

374.21%754.00K

1161.90%530.00K

104.22%339.00K

35.90%265.00K

22.31%159.00K

-70.21%42.00K

23.88%166.00K

47.97%195.00K

137.07%130.00K

24.75%141.00K

33.54%134.00K

-29.14%131.79K

-40.80%54.84K

--113.03K

6.16%100.35K

151.89%186.00K

16.50%92.63K

----

21.00%94.52K

--73.84K

-11.05%79.51K

-18.61%76.44K

-18.24%78.12K

--89.39K

--93.91K

--95.55K

其他營業費用

----

107.33%53.00K

93.44%-446.00K

100.00%0.00

---723.00K

---6.80M

---1.58M

---2.03M

----

營業利潤

-88.73%-14.86M

-663.78%-11.30M

-224.63%-10.18M

-121.45%-9.25M

-347.47%-7.87M

68.90%-1.48M

-131.71%-3.13M

-214.53%-4.18M

86.95%-1.76M

58.69%-4.76M

181.25%9.89M

129.58%3.65M

-80.81%-13.48M

-4.73%-11.52M

36.00%-12.17M

26.44%-12.33M

-47.40%-7.46M

11.38%-11.00M

-46.26%-19.01M

-260.06%-16.76M

-31.20%-5.06M

-833.16%-12.41M

-346.09%-13.00M

61.94%-4.66M

63.91%-3.86M

89.48%-1.33M

62.66%-2.91M

-445.25%-12.23M

-31.31%-10.68M

-294.96%-12.65M

-50.53%-7.80M

71.58%-2.24M

-1.63%-8.14M

201.29%6.49M

16.08%-5.18M

-36.17%-7.89M

-82.75%-8.01M

-149.67%-6.40M

-59.23%-6.18M

-63.97%-5.80M

-18.35%-4.38M

---2.57M

-110.74%-3.88M

-27.60%-3.53M

-451.44%-3.70M

---1.84M

---2.77M

---671.22K

淨非營業利息收入（費用）

利息收入

42.69%1.07M

--520.00K

271.60%628.00K

243.28%690.00K

774.42%752.00K

----

-69.22%169.00K

-58.98%201.00K

-75.91%86.00K

29.63%455.00K

127.80%549.00K

271.21%490.00K

--357.00K

--351.00K

5925.00%241.00K

4300.00%132.00K

----

-92.73%4.00K

-97.67%3.00K

-99.06%3.00K

-97.91%8.00K

-85.41%55.00K

-71.27%129.00K

-36.96%319.00K

-18.90%382.00K

-25.20%377.00K

-32.18%449.00K

55.69%506.00K

210.41%471.00K

524900.00%504.00K

987959.70%662.00K

324900.00%325.00K

--151.74K

--96.00

--67.00

--100.00

----

利息費用

67.82%2.04M

-59.72%1.74M

--1.51M

--1.35M

50.93%1.22M

--4.32M

----

--805.00K

----

出售證券收益

----

---610.00K

----

特殊收入（費用）

214.67%86.00K

93.45%-99.00K

---320.00K

---118.00K

-29.31%-75.00K

-685.66%-1.51M

100.00%0.00

----

---58.00K

-92.39%258.00K

-1577.72%-21.69M

----

209.68%3.39M

-18.17%1.47M

48.74%1.18M

--2.13M

--1.09M

--1.79M

--796.00K

----

其他非經營性收入（費用）

-114.29%-32.00K

-104.96%-92.00K

-56.96%34.00K

45.34%561.00K

--224.00K

444.42%1.85M

-84.39%79.00K

339.75%386.00K

100.00%0.00

-65.54%-538.00K

-30.01%506.00K

-123.82%-161.00K

-124.89%-57.00K

-185.98%-325.00K

6.64%723.00K

45.69%676.00K

-74.10%229.00K

120.62%378.00K

150.63%678.00K

209.43%464.00K

1573.33%884.00K

-1135.59%-1.83M

-2334.55%-1.34M

-1943.48%-424.00K

64.91%-60.00K

-46.53%177.00K

-104.80%-55.00K

-98.13%23.00K

81.06%-171.00K

-66.73%331.00K

166.35%1.15M

189.14%1.23M

-7817.29%-903.00K

16694.23%994.89K

-9376.58%-1.73M

-1471.48%-1.38M

-94.67%11.70K

-21.85%5.92K

-845.72%-18.24K

-2058.10%-87.80K

28459.17%219.62K

--7.58K

-1403.38%-1.93K

115.47%4.48K

31.90%769.00

--148.00

--2.08K

--583.00

稅前利潤

-92.63%-15.77M

-109.63%-12.71M

-292.97%-11.35M

-163.82%-9.47M

-222.75%-8.19M

-32.31%-6.07M

73.15%-2.89M

-190.29%-3.59M

80.76%-2.54M

43.42%-4.58M

-10.44%-10.75M

138.46%3.98M

-158.44%-13.18M

15.00%-8.10M

41.12%-9.74M

33.29%-10.34M

-22.27%-5.10M

33.04%-9.53M

-15.77%-16.54M

-213.09%-15.50M

-15.99%-4.17M

-1746.43%-14.24M

-451.04%-14.28M

57.90%-4.95M

65.24%-3.60M

93.49%-771.00K

57.87%-2.59M

-3249.86%-11.76M

-18.75%-10.35M

-255.17%-11.85M

11.00%-6.15M

96.21%-351.00K

-9.01%-8.71M

219.34%7.63M

-11.57%-6.91M

-57.59%-9.27M

-92.11%-7.99M

-133.61%-6.40M

-59.62%-6.20M

-66.66%-5.88M

-12.32%-4.16M

---2.74M

-91.96%-3.88M

-22.50%-3.53M

-375.01%-3.70M

---2.02M

---2.88M

---779.92K

所得稅

--0.00

----

--0.00

----

--164.00K

----

100.00%0.00

--0.00

100.00%0.00

--0.00

-214.21%-164.00K

-100.00%0.00

-118.19%-148.00K

--0.00

-11.35%143.59K

--145.70K

--813.71K

--0.00

-0.89%161.97K

-100.00%0.00

--0.00

--163.43K

--40.44K

--0.00

100.00%0.00

--0.00

---18.00

除稅後利潤

-92.63%-15.77M

-109.63%-12.71M

-292.97%-11.35M

-163.82%-9.47M

-222.75%-8.19M

-32.31%-6.07M

73.15%-2.89M

-190.29%-3.59M

80.76%-2.54M

43.42%-4.58M

-10.44%-10.75M

138.46%3.98M

-158.44%-13.18M

15.00%-8.10M

41.12%-9.74M

33.29%-10.34M

-22.27%-5.10M

33.81%-9.53M

-15.77%-16.54M

-213.09%-15.50M

-15.99%-4.17M

-1767.70%-14.40M

-451.04%-14.28M

57.90%-4.95M

65.24%-3.60M

93.40%-771.00K

57.87%-2.59M

-5692.12%-11.76M

-18.75%-10.35M

-255.96%-11.68M

12.83%-6.15M

97.99%-203.00K

-9.01%-8.71M

214.21%7.49M

-13.92%-7.06M

-71.42%-10.08M

-92.11%-7.99M

-126.03%-6.56M

-57.98%-6.20M

-66.66%-5.88M

-12.32%-4.16M

---2.90M

-93.96%-3.92M

-22.50%-3.53M

-375.02%-3.70M

---2.02M

---2.88M

---779.90K

持續經營利潤

-92.63%-15.77M

-109.63%-12.71M

-292.97%-11.35M

-163.82%-9.47M

-222.75%-8.19M

-32.31%-6.07M

73.15%-2.89M

-190.29%-3.59M

80.76%-2.54M

43.42%-4.58M

-10.44%-10.75M

138.46%3.98M

-158.44%-13.18M

15.00%-8.10M

41.12%-9.74M

33.29%-10.34M

-22.27%-5.10M

33.81%-9.53M

-15.77%-16.54M

-213.09%-15.50M

-15.99%-4.17M

43.46%-14.40M

-451.04%-14.28M

57.90%-4.95M

65.24%-3.60M

-118.02%-25.47M

57.87%-2.59M

-5692.12%-11.76M

-18.75%-10.35M

-255.96%-11.68M

12.83%-6.15M

97.99%-203.00K

-9.01%-8.71M

214.21%7.49M

-13.92%-7.06M

-71.42%-10.08M

-92.11%-7.99M

-126.03%-6.56M

-57.98%-6.20M

-66.66%-5.88M

-12.32%-4.16M

---2.90M

-93.96%-3.92M

-22.50%-3.53M

-375.02%-3.70M

---2.02M

---2.88M

---779.90K

反常淨利潤

----

--0.00

----

其他淨損益

----

---24.70M

----

歸属于母公司的淨利潤

-92.63%-15.77M

-109.63%-12.71M

-292.97%-11.35M

-163.82%-9.47M

-199.82%-8.19M

-32.31%-6.07M

73.15%-2.89M

-190.29%-3.59M

79.29%-2.73M

43.42%-4.58M

-10.44%-10.75M

138.46%3.98M

-158.44%-13.18M

15.00%-8.10M

41.12%-9.74M

33.29%-10.34M

-22.27%-5.10M

33.81%-9.53M

-15.77%-16.54M

-213.09%-15.50M

-15.99%-4.17M

-299.89%-14.40M

-451.04%-14.28M

57.90%-4.95M

65.24%-3.60M

69.17%-3.60M

57.87%-2.59M

-5692.12%-11.76M

-18.75%-10.35M

-255.96%-11.68M

12.83%-6.15M

97.99%-203.00K

-9.01%-8.71M

214.21%7.49M

-13.92%-7.06M

-71.42%-10.08M

-92.11%-7.99M

-126.03%-6.56M

-57.98%-6.20M

-66.66%-5.88M

-12.32%-4.16M

---2.90M

-93.96%-3.92M

-22.50%-3.53M

-375.02%-3.70M

---2.02M

---2.88M

---779.90K

優先股派息

----

--0.00

-100.00%0.00

--0.00

----

--194.00K

----

--2.83M

----

歸屬普通股東的淨利潤

-92.63%-15.77M

-109.63%-12.71M

-292.97%-11.35M

-163.82%-9.47M

-199.82%-8.19M

-32.31%-6.07M

73.15%-2.89M

-190.29%-3.59M

79.29%-2.73M

43.42%-4.58M

-10.44%-10.75M

138.46%3.98M

-158.44%-13.18M

15.00%-8.10M

41.12%-9.74M

33.29%-10.34M

-22.27%-5.10M

33.81%-9.53M

-15.77%-16.54M

-213.09%-15.50M

-15.99%-4.17M

-299.89%-14.40M

-451.04%-14.28M

57.90%-4.95M

65.24%-3.60M

69.17%-3.60M

57.87%-2.59M

-5692.12%-11.76M

-18.75%-10.35M

-255.96%-11.68M

12.83%-6.15M

97.99%-203.00K

-9.01%-8.71M

214.21%7.49M

-13.92%-7.06M

-71.42%-10.08M

-92.11%-7.99M

-126.03%-6.56M

-57.98%-6.20M

-66.66%-5.88M

-12.32%-4.16M

---2.90M

-93.96%-3.92M

-22.50%-3.53M

-375.02%-3.70M

---2.02M

---2.88M

---779.90K

基本每股收益

-62.14%-1.20

10.86%-1.07

53.12%-1.03

68.99%-0.86

51.81%-0.74

67.57%-1.20

74.87%-2.19

-176.14%-2.76

89.10%-1.54

57.45%-3.70

16.89%-8.70

132.53%3.63

-155.65%-14.15

17.65%-8.71

46.40%-10.47

44.29%-11.16

6.63%-5.54

48.61%-10.57

7.11%-19.53

-164.86%-20.03

-13.75%-5.93

-279.12%-20.57

-400.48%-21.03

60.45%-7.56

67.97%-5.21

68.55%-5.43

53.83%-4.20

-6255.32%-19.12

-16.82%-16.27

-229.15%-17.26

28.47%-9.10

98.38%-0.30

6.20%-13.93

209.68%13.36

-10.53%-12.72

-61.36%-18.59

-77.70%-14.85

-108.96%-12.18

-42.67%-11.51

-20.03%-11.52

17.02%-8.36

---5.83

41.01%-8.07

50.76%-9.60

-375.02%-10.07

---13.68

---19.49

---2.12

稀釋每股收益

-62.14%-1.20

10.86%-1.07

53.12%-1.03

68.99%-0.86

51.81%-0.74

67.57%-1.20

74.87%-2.19

-176.31%-2.76

89.10%-1.54

57.45%-3.70

16.89%-8.70

132.46%3.62

-155.65%-14.15

17.65%-8.71

46.40%-10.47

44.29%-11.16

6.63%-5.54

48.61%-10.57

7.11%-19.53

-164.86%-20.03

-13.75%-5.93

-279.12%-20.57

-400.48%-21.03

60.45%-7.56

67.97%-5.21

68.55%-5.43

53.83%-4.20

-6255.32%-19.12

-16.82%-16.27

-229.15%-17.26

28.47%-9.10

98.38%-0.30

6.20%-13.93

209.68%13.36

-10.53%-12.72

-61.36%-18.59

-77.70%-14.85

-108.96%-12.18

-42.67%-11.51

-20.03%-11.52

17.02%-8.36

---5.83

41.01%-8.07

50.76%-9.60

-375.02%-10.07

---13.68

---19.49

---2.12

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Palvella Therapeutics Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 PVLA 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Palvella Therapeutics Inc 全年的淨利潤是多少？



Palvella Therapeutics Inc 2025 財年淨利潤為 -41.72M。

Palvella Therapeutics Inc 上一季度的淨利潤是多少？



Palvella Therapeutics Inc 最近一個季度的淨利潤為 -15.77M。

Palvella Therapeutics Inc 年度營業利潤是多少？



Palvella Therapeutics Inc 2025 財年的營業利潤為 -38.60M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。